In June 2022, the independent review panel recommended that bringing the sponsor function in-house should be viewed as a pragmatic measure – the sponsor body governance model could be made to work but was unlikely to be viable given the “extent of lost confidence and momentum for bringing the sponsor function in-house…attempting to retaining the current model is unlikely to be viable”. Looking ahead, the expert panel recommended that “The governance model for the delivery phase will need to be separately considered and confirmed after the R&R scope and preferred delivery strategy is agreed”.59